- Filed
- May 8, 2025 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Long Term Debt | Q1 2025 · Mar 31, 2025 | $260.77M |
| Long Term Debt | Q1 2025 · Dec 31, 2024 | $219.76M |
| Short Term Debt | Q1 2025 · Mar 31, 2025 | $22.63M |
| Short Term Debt | Q1 2025 · Dec 31, 2024 | $17.31M |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $316.44M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $293.35M |
| Stockholders Equity | Q1 2025 · Mar 31, 2025 | $599.06M |
| Stockholders Equity | Q1 2025 · Dec 31, 2024 | $537.37M |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $196.75M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $203.07M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $1.97B |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $1.74B |
| Current Assets | Q1 2025 · Mar 31, 2025 | $382.88M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $357.94M |
| Total Assets | Q1 2025 · Mar 31, 2025 | $2.77B |
| Total Assets | Q1 2025 · Dec 31, 2024 | $2.5B |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 83.41M sh |
| Capex | Q1 2025 · Mar 31, 2024 | $57.46M |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | $41.19M |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | $0.08 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | $0.08 |
| Sga Expense | Q1 2025 · Mar 31, 2024 | $46.19M |
| Net Income | Q1 2025 · Mar 31, 2024 | $7.06M |
| Operating Income | Q1 2025 · Mar 31, 2024 | $25.58M |
| Cost Of Revenue | Q1 2025 · Mar 31, 2024 | $203.33M |
| Revenue | Q1 2025 · Mar 31, 2024 | $275.1M |